A detailed history of Northeast Financial Consultants Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 16,867 shares of ABBV stock, worth $3.02 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
16,867
Previous 16,830 0.22%
Holding current value
$3.02 Million
Previous $2.89 Million 15.38%
% of portfolio
0.15%
Previous 0.13%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $6,062 - $7,375
37 Added 0.22%
16,867 $3.33 Million
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $108,353 - $126,532
-700 Reduced 3.99%
16,830 $2.89 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $189,067 - $215,424
1,183 Added 7.24%
17,530 $3.19 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $288,020 - $333,425
-2,156 Reduced 11.65%
16,347 $2.44 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $2,915 - $3,627
22 Added 0.12%
18,503 $2.49 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $252,344 - $290,612
-1,745 Reduced 8.63%
18,481 $2.95 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $262,097 - $314,323
1,895 Added 10.34%
20,226 $3.27 Million
Q3 2022

Nov 15, 2022

BUY
$134.21 - $153.93 $111,394 - $127,761
830 Added 4.74%
18,331 $2.46 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $78,718 - $100,077
-572 Reduced 3.16%
17,501 $2.68 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $39,857 - $49,452
302 Added 1.7%
18,073 $2.93 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $142,452 - $180,243
-1,326 Reduced 6.94%
17,771 $2.41 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $24,152 - $27,417
227 Added 1.2%
19,097 $2.06 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $6,523 - $7,267
-62 Reduced 0.33%
18,870 $2.13 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $21,380 - $23,537
209 Added 1.12%
18,932 $2.05 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $41,322 - $48,499
481 Added 2.64%
18,723 $1.64 Million
Q2 2020

Jul 30, 2020

BUY
$73.37 - $98.18 $494,807 - $662,125
6,744 Added 58.65%
18,242 $1.79 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $645 - $977
10 Added 0.09%
11,498 $876,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $41,546 - $51,984
576 Added 5.28%
11,488 $1.02 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $8,565 - $10,297
136 Added 1.26%
10,912 $826,000
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $7,029 - $8,985
107 Added 1.0%
10,776 $784,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $4,474 - $5,265
-58 Reduced 0.54%
10,669 $860,000
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $483,915 - $596,798
6,216 Added 137.8%
10,727 $989,000
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $141,455 - $157,254
1,591 Added 54.49%
4,511 $426,000
Q1 2018

Apr 19, 2018

SELL
$92.01 - $123.21 $29,811 - $39,920
-324 Reduced 9.99%
2,920 $276,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $29,017 - $31,820
324 Added 11.1%
3,244 $313,000
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $203,961 - $260,522
2,920
2,920 $259,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.